-
Americas
-
Asia & Oceania
-
A-I
J-Z
EMEA Thought Leadership
Developing IQVIA’s positions on key trends in the pharma and life sciences industries, with a focus on EMEA.
Learn more -
Middle East & Africa
EMEA Thought Leadership
Developing IQVIA’s positions on key trends in the pharma and life sciences industries, with a focus on EMEA.
Learn more
Regions
-
Americas
-
Asia & Oceania
-
Europe
-
Middle East & Africa
-
Americas
-
Asia & Oceania
-
Europe
Europe
- Adriatic
- Belgium
- Bulgaria
- Czech Republic
- Deutschland
- España
- France
- Greece
- Hungary
- Ireland
- Israel
- Italia
EMEA Thought Leadership
Developing IQVIA’s positions on key trends in the pharma and life sciences industries, with a focus on EMEA.
Learn more -
Middle East & Africa
EMEA Thought Leadership
Developing IQVIA’s positions on key trends in the pharma and life sciences industries, with a focus on EMEA.
Learn more
SOLUTIONS
-
Research & Development
-
Real World Evidence
-
Commercialization
-
Safety & Regulatory Compliance
-
Technologies
LIFE SCIENCE SEGMENTS
HEALTHCARE SEGMENTS
- Information Partner Services
- Financial Institutions
- Global Health
- Government
- Patient Associations
- Payers
- Providers
THERAPEUTIC AREAS
- Cardiovascular
- Cell and Gene Therapy
- Central Nervous System
- GI & Hepatology
- Infectious Diseases and Vaccines
- Oncology
- Pediatrics
- Rare Diseases
- View All
Impacting People's Lives
"We strive to help improve outcomes and create a healthier, more sustainable world for people everywhere.
LEARN MORE
Harness the power to transform clinical development
Reimagine clinical development by intelligently connecting data, technology, and analytics to optimize your trials. The result? Faster decision making and reduced risk so you can deliver life-changing therapies faster.
Research & Development OverviewResearch & Development Quick Links
Real World Evidence. Real Confidence. Real Results.
Generate and disseminate evidence that answers crucial clinical, regulatory and commercial questions, enabling you to drive smarter decisions and meet your stakeholder needs with confidence.
REAL WORLD EVIDENCE OVERVIEWReal World Evidence Quick Links
See markets more clearly. Opportunities more often.
Elevate commercial models with precision and speed using AI-driven analytics and technology that illuminate hidden insights in data.
COMMERCIALIZATION OVERVIEWCommercialization Quick Links
Service driven. Tech-enabled. Integrated compliance.
Orchestrate your success across the complete compliance lifecycle with best-in-class services and solutions for safety, regulatory, quality and medical information.
COMPLIANCE OVERVIEWSafety & Regulatory Compliance Quick Links
Intelligence that transforms life sciences end-to-end.
When your destination is a healthier world, making intelligent connections between data, technology, and services is your roadmap.
TECHNOLOGIES OVERVIEWTechnology Quick Links
CLINICAL PRODUCTS
COMMERCIAL PRODUCTS
COMPLIANCE, SAFETY, REG PRODUCTS
BLOGS, WHITE PAPERS & CASE STUDIES
Explore our library of insights, thought leadership, and the latest topics & trends in healthcare.
DISCOVER INSIGHTSTHE IQVIA INSTITUTE
An in-depth exploration of the global healthcare ecosystem with timely research, insightful analysis, and scientific expertise.
SEE LATEST REPORTS
FEATURED INNOVATIONS
-
IQVIA Connected Intelligence™
-
IQVIA Healthcare-grade AI™
-
IQVIA AI Assistant
-
Human Data Science Cloud
-
IQVIA Innovation Hub
-
Decentralized Trials
-
Patient Experience Solutions with Apple devices
WHO WE ARE
- Our Story
- Our Impact
- Commitment to Global Health
- Code of Conduct
- Sustainability
- Privacy
- Executive Team
NEWS & RESOURCES
Unlock your potential to drive healthcare forward
By making intelligent connections between your needs, our capabilities, and the healthcare ecosystem, we can help you be more agile, accelerate results, and improve patient outcomes.
LEARN MORE
IQVIA AI is Healthcare-grade AI
Building on a rich history of developing AI for healthcare, IQVIA AI connects the right data, technology, and expertise to address the unique needs of healthcare. It's what we call Healthcare-grade AI.
LEARN MORE
Meet the IQVIA AI Assistant
Your new expert analyst is here. Be at the forefront of data-driven decision-making with a new generative AI tool that enables you to interact with our products and solutions like never before. Get results you can trust, faster.
LEARN MORE
Your healthcare data deserves more than just a cloud.
The IQVIA Human Data Science Cloud is our unique capability designed to enable healthcare-grade analytics, tools, and data management solutions to deliver fit-for-purpose global data at scale.
LEARN MORE
Innovations make an impact when bold ideas meet powerful partnerships
The IQVIA Innovation Hub connects start-ups with the extensive IQVIA network of assets, resources, clients, and partners. Together, we can help lead the future of healthcare with the extensive IQVIA network of assets, resources, clients, and partners.
LEARN MORE
Proven, faster DCT solutions
IQVIA Decentralized Trials deliver purpose-built clinical services and technologies that engage the right patients wherever they are. Our hybrid and fully virtual solutions have been used more than any others.
LEARN MORE
IQVIA Patient Experience Solutions with Apple devices
Empowering patients to personalize their healthcare and connecting them to caregivers has the potential to change the care delivery paradigm.
LEARN MOREIQVIA Careers
Featured Careers
Stay Connected
WE'RE HIRING
"At IQVIA your potential has no limits. We thrive on bold ideas and fearless innovation. Join us in reimagining what’s possible.
VIEW ROLESBlog
IQVIA at DIA 2022: DAY 4 Recap
Jun 23, 2022
The time has come for us to say goodbye to fellow attendees, as DIA 2022 wraps up today. The IQVIA team was especially excited to join so many of our fellow experts in drug development and clinical trials, leaders in regulatory, advocacy, pharmaceuticals and academia and the patients we aim to serve.
In the fight against COVID-19 over the last few years, we experienced a united urgency from the wider healthcare ecosystem to embrace innovation and find viable solutions to speed up decision-making and set up and execute trial programs with patients in mind. That is why sharing our firsthand experience and insights in working through the pandemic with increased innovation at this year’s DIA was important to do.
Through various DIA sessions and panel discussions and more, IQVIA experts helped to shed light on how to successfully continue, and in some cases, accelerate drug development by aiming to make intelligent connections between expertise, unparalleled breadth of data, tech-enabled solutions and advanced analytics. These activities provided the opportunity for experts to team up with other industry luminaries to discuss perspectives, best practices and lessons learned for various stages of drug development.
Some notable topics of discussion, included:
- Enhancing patient centricity in clinical trials:
- President of Design and Delivery Innovation at IQVIA Cyndi Verst led the Innovation Theater presentation, “Redefining Patient Centricity in a Post-Pandemic Era”. As the global COVID-19 pandemic forced our industry to think outside the status quo box, Cyndi discussed the innovative ways IQVIA successfully engaged patients, leveraged transformative technologies and accelerated trial processes by keeping focus on one thing: patient centricity. Looking ahead, the session explored how to take the best of these innovations and turn them into patient-centric best practices for future clinical trials.
- In aiming to better address diversity in clinical trials, IQVIA experts participated in several key sessions:
- In the “Approaches to Addressing Diversity and Inclusion in Clinical Research” session, Vice President of the Analytics Center of Excellence at IQVIA Lucas Glass shared his recommendations on how sponsors can leverage artificial intelligence (AI) and machine learning (ML) to better inform trial site selection and optimize enrollment among diverse patient populations.
- During the “Leveraging Real-World Evidence (RWE) to Address Diversity Gaps in Randomized Clinical Trials: Regulatory, Clinical and Other Considerations” DIAmond session, IQVIA’s Chief Scientific Officer Nancy Dreyer chaired a panel discussion on how the lack of diversity in trials can impact the reliability of evidence-based care algorithms and to provide attendees with insight how RWE can supplement randomized clinical trials to fill evidence gaps and better address diversity.
- The many uses of RWE in drug development:
- Through the Innovation Theater presentation on “RWE to Enhance Clinical Development”https://sched.co/zLXY. IQVIA’s Medical Affairs Category Lead for Real World Evidence Barbara Isquith Arone helped showcase the new uses of RWE, including: supporting trial design; providing context for interventional studies and helping to create practical approaches to the long term monitoring of cell and gene therapies.
- During the “Post-Approval Safety Studies: Approaches to Assessing Medication Exposure and Potential Safety Risks During Pregnancy,” Senior Principal of Real World Strategy and Innovation at IQVIA Lockwood Taylor shared insights on how RWD and related evidence from claims and electronic health record databases may help address some of the long-standing challenges in collecting pregnancy safety information in a post-marketing setting via registries and in evaluating drug safety during pregnancy.
- At the “FDA Real-World Evidence Guidance for Regulatory Approval: Implications for Evidence Needs for Payers and Population-Based Decision Makers and Healthcare Providers” forum, IQVIA’s Vice President of Real World Evidence Matthew Reynolds highlighted discuss what is necessary to ensure real-world data (RWD) using in generating real-world evidence (RWE) meets the new draft U.S. Food and Drug Administration (FDA) guidance recommendations.
The give and take of knowledge and experience we are able to have at this important industry meeting allows us to go back to our work more motivated and inspired to tackle the challenges of today’s clinical development environment. And, we know we can rely on strong collaborations with others to discover new paths and possibilities in clinical research for patients in need.
DIA 2022 is officially in the books! IQVIA thanks the organizers and attendees for another productive gathering!
If interested in connecting with IQVIA experts to learn more about our services, please contact us here.